D-0236-2017 Class II Terminated
FDA drug recall D-0236-2017 was initiated by Sandoz Incorporated on Dec 22, 2016 and is designated Class II. Reason for recall: Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%) The recall status is terminated (terminated Sep 18, 2017). Affected quantity: 96 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 4, 2017
- Initiation Date
- Dec 22, 2016
- Termination Date
- Sep 18, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 96 bottles
Product description
Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10
Reason for recall
Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)
Distribution pattern
MS and OH.
Code information
Lot GG1539
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0236-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026